Latest news
Neurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 13:34:39 GMTBioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMTFridge-free tetanus-diphtheria vaccine passes first human trial - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 09:55:37 GMTFMT Shows Promise for Peanut Allergy Tolerance in Phase I Trial - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Fri, 07 Aug 2026 03:24:01 GMTModerna kicks off Phase I Ebola trial as Africa readies itself for research - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 18:00:37 GMTPhase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma - The ASCO PostThe ASCO Post · Wed, 05 Aug 2026 14:32:11 GMTWhat Oblenio’s Phase I trial means for autoimmune drug discovery - Drug Target ReviewDrug Target Review · Wed, 05 Aug 2026 14:00:01 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMT